Publications
- Highly active relapse / reminent multiple sclerosis and okrelizumab after failure of alemtuzumab treatment2020 | Faculty of Medicine in Hradec Králové
- Induction therapy and multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- Ocrelizumab, clinical activity and progression - long - term data2019 | Faculty of Medicine in Hradec Králové
- Pharmacovigilance of novel treatments for multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- Evalution of multiple sclerosis activity and disability2019 | Faculty of Medicine in Hradec Králové
- Alemtuzumab treatment in multiple slerosis: real clinical experience2019 | Faculty of Medicine in Hradec Králové
- Current treatment strategies for multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- A comparison of efficacy of subcutaneous interferon beta-1a 44 mu g, dimethyl fumarate and fingolimod in the real-life clinical practise - a multicenter observational study2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Biological treatment in neurology2018 | Faculty of Medicine in Hradec Králové
- Triple rounds- specialists for treatment of multiple sclerosis met in Brno2018 | Faculty of Medicine in Hradec Králové
Loading network view...